Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

Abstract:

PURPOSE OF REVIEW:Significant advances have been made in the treatment of younger patients with acute myeloid leukemia over the past 3 decades, but prognosis in the elderly has remained dismal, with median survival times of only a few months. Although a small percentage of older patients may be cured by standard chemotherapy, it is clear that several aspects of frontline management require improvement and novel approaches are urgently needed. This review focuses on treatment options currently available to older patients with acute myeloid leukemia, with an emphasis on new therapeutics. RECENT FINDINGS:Developing risk-assessment tools is critical to identify older patients who are most likely to benefit from intensive chemotherapy, but optimal induction and postremission therapies have yet to be determined in this population. New strategies and treatments are emerging and under current assessment. In particular, investigations of monoclonal antibodies, hypomethylating agents, signal transduction inhibitors, and novel cytotoxics hold promise for improving outcomes in older patients with acute myeloid leukemia, including those for whom traditional chemotherapy is not considered appropriate. SUMMARY:Acute myeloid leukemia remains a therapeutic challenge in elderly patients, but, following a period of paucity in discoveries, several new treatments are finally emerging that may offer future improvement for these patients.

journal_name

Curr Opin Oncol

authors

Amadori S,Del Principe MI,Venditti A

doi

10.1097/CCO.0000000000000124

subject

Has Abstract

pub_date

2014-11-01 00:00:00

pages

663-9

issue

6

eissn

1040-8746

issn

1531-703X

journal_volume

26

pub_type

杂志文章,评审
  • Brain metastases: current management and new developments.

    abstract:PURPOSE OF REVIEW:To review the state-of-the-art and new developments in the management of patients with brain metastases. RECENT FINDINGS:Treatment decisions are based on prognostic factors to maximize neurologic function and survival, while avoiding unnecessary therapies. Whole-brain radiotherapy (WBRT) is the treat...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32831186fe

    authors: Soffietti R,Rudà R,Trevisan E

    更新日期:2008-11-01 00:00:00

  • Corrupt policemen: inflammatory cells promote tumor angiogenesis.

    abstract:PURPOSE OF REVIEW:The last decade has seen a paradigm change in that tumor stroma contributes to malignant tumor progression in a manner comparable to genetic and epigenetic changes within cancer cells. This review summarizes recent novel insights into how inflammatory conditions stimulate the formation and expansion o...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32831bed7e

    authors: Zumsteg A,Christofori G

    更新日期:2009-01-01 00:00:00

  • An update on noninvasive follicular thyroid neoplasm with papillary-like nuclear features.

    abstract:PURPOSE OF REVIEW:Noninvasive encapsulated follicular variant of papillary thyroid carcinoma (PTC) has been established in the literature as a clinically indolent tumor. Despite this, it was traditionally treated like all other PTCs. In an attempt to reduce overtreatment of this entity, a panel of experts reclassified ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000416

    authors: Range DE,Jiang XS

    更新日期:2018-01-01 00:00:00

  • Environmental estrogens and breast cancer risk.

    abstract::Controversy exists over the role that environmental estrogens, such as pesticides or polychlorinated biphenyls (PCBs), might play as risk factors for breast cancer. Several laboratory studies have suggested that these chemicals function as weak estrogens, binding to the estrogen receptor and inducing various measures ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199809000-00018

    authors: Davidson NE

    更新日期:1998-09-01 00:00:00

  • Osteosarcoma and other bone cancers.

    abstract::In this review, recent advances in the clinical therapy of osteosarcoma, including results from the European Osteosarcoma Intergroup trial demonstrating the efficacy of a short intensive two drug protocol are discussed as well the evolving role of ifosfamide. Biologically, the area of interest on chromosome 3q, which ...

    journal_title:Current opinion in oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1097/00001622-199807000-00009

    authors: Himelstein BP

    更新日期:1998-07-01 00:00:00

  • Screening, staging, and diagnostic investigation of non-small cell lung cancer patients.

    abstract::Despite its appeal, lung cancer screening has been found to be of little value at this time. However, use of monoclonal antibodies to detect cancer cells in the sputum may prove to be of value in high-risk subjects. Once a cancer is diagnosed, anatomic staging by the International TNM Staging System has shown its effe...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199104000-00010

    authors: Shields TW

    更新日期:1991-04-01 00:00:00

  • Surgical management of the lateral neck compartment for metastatic thyroid cancer.

    abstract:PURPOSE OF REVIEW:The lateral neck compartment is the second most frequent target region for metastatic papillary thyroid cancer (PTC) and medullary thyroid cancer (MTC). Lateral lymph node metastases are associated with locoregional recurrence and, when they involve either side of the neck, with mediastinal and distan...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328359ff1f

    authors: Dralle H,Machens A

    更新日期:2013-01-01 00:00:00

  • Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

    abstract::Tyrosine kinase (type 1) growth factor receptors include the erbB family. These cell surface receptors were discovered in the context of cellular transformation and have subsequently been found to be overexpressed in many types of human cancer. Cumulative evidence suggests that upregulation of the most well-characteri...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200105000-00007

    authors: Lango MN,Shin DM,Grandis JR

    更新日期:2001-05-01 00:00:00

  • The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

    abstract:PURPOSE OF REVIEW:To review recent observations that describe changes in the likelihood of invasive fungal infections, shifts in types of fungal pathogens, and altered manifestations of fungal syndromes after hematopoietic cell transplantation and explore how changes in transplant practices are influencing these epidem...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000152975.65477.7c

    authors: Wingard JR

    更新日期:2005-03-01 00:00:00

  • Advances in the biology and treatment of multiple myeloma.

    abstract::Advances in the understanding of the cellular and molecular derangements involved in the initiation and progression of multiple myeloma are beginning to be translated into novel therapeutic approaches. The myeloma stem cell has been under intense scrutiny regarding its normal B-cell counterpart. Oncogenes, tumor-suppr...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199901000-00002

    authors: Varterasian ML

    更新日期:1999-01-01 00:00:00

  • Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancer.

    abstract:PURPOSE OF REVIEW:The review aims at comprehensively discussing our current knowledge on bone metastases incidence in non-small cell lung cancer (NSCLC), their related complications as well as clinical impact in patients suffering from advanced disease. RECENT FINDINGS:After evoking the use of zoledronic acid as the e...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835d720b

    authors: Peters S,Meylan E

    更新日期:2013-03-01 00:00:00

  • Novel immunologic approaches to the management of malignant melanoma.

    abstract::In the past decade, the discovery of tumor antigens recognized by T cells has revolutionized the tumor vaccine field. The appreciation that peptides are bound to and restricted by major histocompatibility class I and II molecules for immune recognition has encouraged a number of early-phase clinical trials of peptide ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200103000-00007

    authors: Weber JS,Aparicio A

    更新日期:2001-03-01 00:00:00

  • Surgical considerations for management of distal extremity soft tissue sarcomas.

    abstract:PURPOSE OF REVIEW:This review focuses on the surgical management of soft tissue sarcomas of the hands and the feet. With recent advances in limb salvage surgery and radiotherapy delivery, local control of soft tissue sarcoma in the extremity has become optimized, and the associated functional results of this treatment ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000166651.38417.c8

    authors: Ferguson PC

    更新日期:2005-07-01 00:00:00

  • Update in germ cell tumours.

    abstract:PURPOSE OF REVIEW:The purpose of this study is to update the reader on advances in postpubertal male germ cell tumours (GCTs) over the last 18 months. RECENT FINDINGS:Single nucleotide polymorphisms, including in four sex-determination genes, have been identified as additional genetic susceptibility loci to testicular...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000179

    authors: Feldman DR

    更新日期:2015-05-01 00:00:00

  • Chondrosarcoma and other rare bone sarcomas.

    abstract::The clinical staging of bone tumors, even rare ones, has been much improved with the availability of better imaging techniques. Once diagnosis of a rare bone tumor has been made, close consultation between clinician, radiologist, and pathologist is essential for optimal treatment. Recent advances in the staging proced...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Dirix LY,Van Oosterom AT

    更新日期:1991-08-01 00:00:00

  • Anal carcinoma: histology, staging, epidemiology, treatment.

    abstract::Our understanding of the pathogenesis and management of squamous cell carcinoma of the anal canal has undergone profound change over the last 30 years. Epidemiologic studies have demonstrated that infection with human papillomavirus is most likely responsible for the majority of cases. Primary treatment with concomita...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200007000-00011

    authors: Ryan DP,Mayer RJ

    更新日期:2000-07-01 00:00:00

  • Update on the pathogenesis and treatment of Kaposi sarcoma.

    abstract::Kaposi sarcoma (KS), an unusual tumor of vascular origin, was one of the first recognized manifestations of AIDS. In the past few years, it has become clear that human herpesvirus-8 (HHV-8) is critical to the development of KS in the setting of immunosuppression, such as that seen with HIV infection. Other genetic and...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200003000-00013

    authors: Mitsuyasu RT

    更新日期:2000-03-01 00:00:00

  • Tackling immunomonitoring in gastrointestinal cancer.

    abstract:PURPOSE OF REVIEW:The growing awareness that the immune system is a key player in the antitumoral response and the excellent clinical results achieved in some settings with anti-programmed cell death 1 (PD1)/programmed death ligand 1 (PDL1) and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) drugs has led to t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000383

    authors: Anciaux M,Vandeputte C,Hendlisz A

    更新日期:2017-07-01 00:00:00

  • Adult desmoid tumors: biology, management and ongoing trials.

    abstract:PURPOSE OF REVIEW:To summarize the current knowledge about the biology and clinical management of adult desmoid tumors. RECENT FINDINGS:In the past decade, we have learned that desmoid tumors are driven by alterations of the Wnt/APC/β-catenin pathway, sporadic desmoid tumors are associated with somatic mutations of CT...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000374

    authors: Penel N,Chibon F,Salas S

    更新日期:2017-07-01 00:00:00

  • New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.

    abstract:PURPOSE OF REVIEW:Retroperitoneal sarcoma (RPS) is a rare disease, and until recently, its natural history and outcome were poorly understood. Recently, collaborations between individual centers have led to an unprecedented collection of retrospective and prospective data and successful recruitment to the first randomi...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000535

    authors: van Houdt WJ,Raut CP,Bonvalot S,Swallow CJ,Haas R,Gronchi A

    更新日期:2019-07-01 00:00:00

  • Molecular prediction of metastasis in cutaneous squamous cell carcinoma.

    abstract:PURPOSE OF REVIEW:Cutaneous squamous cell carcinoma (cSCC) is a highly prevalent malignancy frequently occurring on body surfaces chronically exposed to ultraviolet radiation. While a large majority of tumors remain localized to the skin and immediate subcutaneous tissue and are cured with surgical excision, a small su...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000609

    authors: Mulvaney PM,Schmults CD

    更新日期:2020-03-01 00:00:00

  • Antisense oligodeoxynucleotides.

    abstract::Oligodeoxynucleotides have been proposed as both in vitro and in vivo inhibitors of gene expression because of the specificity of Watson-Crick base pair hybridization. Phosphodiester oligodeoxynucleotides (normal DNA) cannot be used as drugs because they are nuclease sensitive. Significant efforts have been made to st...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199411000-00010

    authors: Stein CA,Narayanan R

    更新日期:1994-11-01 00:00:00

  • New drug therapy for squamous carcinoma of the head and neck.

    abstract::The identification of new active agents for the treatment of squamous carcinoma of the head and neck remains a high priority for clinical investigators. For the past several years a number of investigational drugs have demonstrated activity in patients with recurrent or metastatic disease. Included are the following a...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199605000-00009

    authors: Murphy BA

    更新日期:1996-05-01 00:00:00

  • Adjuvant therapy of operable nonsmall cell lung cancer: an update.

    abstract:PURPOSE OF REVIEW:The current status of postoperative adjuvant therapy for nonsmall cell lung cancer (NSCLC) is reviewed. RECENT FINDINGS:Cisplatin-based postoperative chemotherapy is a current standard of care for patients with stage II-III NSCLC who underwent complete resection. However, its benefit is limited. In t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/CCO.0000000000000702

    authors: Mitsudomi T,Soh J

    更新日期:2021-01-01 00:00:00

  • Renal cell carcinoma.

    abstract:PURPOSE OF REVIEW:The recent contributions to renal cell carcinoma in the fields of molecular biology and the expanded use of molecularly targeted agents will be reviewed. This study is intended to update prognostic and therapeutic decision-making data and provide perspective on advances in understanding the molecular ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f9782b

    authors: Rini BI,Rathmell WK,Godley P

    更新日期:2008-05-01 00:00:00

  • Primary liver cancers.

    abstract::A review of the recent literature about liver cancers shows the increasing role of hepatitis C as a risk factor for the development of hepatocellular carcinoma. A new discussion has arisen with regard to the association between the use of oral contraceptives and hepatocellular carcinoma. Patients at risk for developin...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199507000-00017

    authors: Weimann A,Oldhafer KJ,Pichlmayr R

    更新日期:1995-07-01 00:00:00

  • Hematopoietic growth factors in lung cancer.

    abstract:PURPOSE OF REVIEW:Most patients affected by lung cancer are treated with chemotherapy, and hence are at risk of myelosuppression. Hematopoietic growth factors have a relevant role in this setting, as they can improve quality of life, reduce the rate of chemotherapy-induced complications and allow the administration of ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000268

    authors: Genova C,Rijavec E,Grossi F

    更新日期:2016-03-01 00:00:00

  • Elderly patients with multiple myeloma: towards a frailty approach?

    abstract:PURPOSE OF REVIEW:To describe how to better identify frail multiple myeloma patients and to treat them appropriately. RECENT FINDINGS:Proteasome inhibitors, such as bortezomib, carfilzomib, and ixazomib, and immunomodulatory agents (IMiDs), such as thalidomide, lenalidomide, and pomalidomide, have significantly improv...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000395

    authors: Zweegman S,Engelhardt M,Larocca A,EHA SWG on ‘Aging and Hematology’.

    更新日期:2017-09-01 00:00:00

  • Metastatic breast cancer.

    abstract::Tamoxifen as adjuvant systemic treatment after first isolated locoregional recurrence of breast cancer has been shown to decrease the subsequent locoregional relapse rate, but it affects neither distant metastases nor survival. In metastatic disease, tamoxifen has not improved response when added to ablation of ovaria...

    journal_title:Current opinion in oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1097/00001622-199511000-00008

    authors: Rubens RD

    更新日期:1995-11-01 00:00:00

  • Bone marrow transplantation for chronic myelogenous leukemia.

    abstract::Chronic myelogenous leukemia (CML) is a hematologic malignancy characterized by an initial chronic phase of expanded clonal myelopoiesis followed by inevitable progression to accelerated phase and finally to fatal blast crisis. Although interferon therapy results in hematologic control of disease in most patients and ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199803000-00003

    authors: Enright H,McGlave P

    更新日期:1998-03-01 00:00:00